Children treated for brain tumours may develop complications long after the cancer is gone. Elizabeth Schepke, senior consultant at Drottning Silvias barn- och ungdomssjukhus, conducts research on how late complications after treatment for medulloblastoma — the most common malignant brain tumour in children — can be prevented and how recovery can be improved.
Elizabeth Schepke named Childhood cancer researcher of the Year 2026
Oncologist Elizabeth Schepke has been named Childhood Cancer Researcher of the Year 2026 by the Swedish Childhood Cancer Foundation.
Advertisement